Resumen de New MS drug approved
* Teriflunomide (Aubagio) has been approved to treat adults with relapsing multiple sclerosis.
* The drug label carries boxed warnings that teriflunomide can produce hepatotoxicity and that its use during pregnancy can cause birth defects.
